TIGAR and breast carcinoma: More and more investigations have been conducted in this field, and they indicate high levels of TIGAR in hematopathy and solid tumors, including acute myeloid leukemia (18), lung cancer (19), colon cancer (20), pancreatic cancer (21) and breast cancer (22).